Inventor · disambiguated record
Howard M. Johnson
Also filed as: JOHNSON HOWARD M · JOHNSON HOWARD MARCELLUS
22 granted patents·5 pending applications·732 citations·filing 1988–2015
97Inventor score
Top patents by PatentIndex Score
27 records- 0193US5942223AAntiviral therapy using ovine or bovine interferon-tauUNIV FLORIDA·Filed 1995·Granted Aug 24, 1999·137 cites·8 claims
- 0285US6060450AMethod for treatment of autoimmune diseasesUNIV FLORIDA·Filed 1999·Granted May 9, 2000·57 cites·12 claims
- 0384US6174996B1Hybrid interferon τ/type I interferon polypeptidesUNIV FLORIDA·Filed 1998·Granted Jan 16, 2001·29 cites·6 claims
- 0484US5906816AMethod for treatment of autoimmune diseasesUNIV FLORIDA·Filed 1995·Granted May 25, 1999·54 cites·11 claims
- 0581US6120762AC-terminal peptides of interferon γUNIV FLORIDA·Filed 1998·Granted Sep 19, 2000·47 cites·11 claims
- 0681US5939286AHybrid interferon tau/alpha polypeptides, their recombinant production, and methods using themUNIV FLORIDA·Filed 1996·Granted Aug 17, 1999·56 cites·9 claims
- 0780US6372206B1Orally-administered interferon-TAU compositions and methodsUNIV FLORIDA·Filed 1996·Granted Apr 16, 2002·29 cites·33 claims
- 0879US6083919AMaterials and methods for treating autoimmune diseaseUNIV FLORIDA·Filed 1997·Granted Jul 4, 2000·50 cites·20 claims
- 0978US6204022B1Low-toxicity human interferon-alpha analogsPEPGEN CORP AND UNIVERSITY OF·Filed 1997·Granted Mar 20, 2001·63 cites·42 claims
- 1076US5545716ASuperantigen agonist and antagonist peptidesUNIV FLORIDA·Filed 1994·Granted Aug 13, 1996·35 cites·4 claims
- 1175US7214367B2Orally-administered interferon-tau compositions and methodsUNIV FLORIDA·Filed 2003·Granted May 8, 2007·2 cites·5 claims
- 1275US5859207ASuperantigen agonist and antagonist peptidesUNIV FLORIDA·Filed 1996·Granted Jan 12, 1999·27 cites·7 claims
- 1375US5770191AActive C-terminal peptides of interferon--gamma and their useUNIV FLORIDA·Filed 1995·Granted Jun 23, 1998·48 cites·19 claims
- 1473US5958402AAntitumor therapy using ovine or bovine interferon-tauUNIV FLORIDA·Filed 1995·Granted Sep 28, 1999·25 cites·6 claims
- 1568US2004146989A1Interferon tau compositions and methods of useUNIV FLORIDA·Filed 2004·Application pending·0 cites
- 1665US5519114ARetroviral superantigens, superantigen peptides, and methods of useUNIV FLORIDA·Filed 1993·Granted May 21, 1996·21 cites·1 claims
- 1761US7189694B2Inhibitors of autophosphorylation protein kinasesUNIV FLORIDA·Filed 2004·Granted Mar 13, 2007·3 cites·50 claims
- 1860US6942854B2Orally-administered interferon-tau compositions and methodsUNIV FLORIDA·Filed 2001·Granted Sep 13, 2005·12 cites·8 claims
- 1960US6403562B1Materials and methods for treating autoimmune diseaseUNIV FLORIDA·Filed 1999·Granted Jun 11, 2002·19 cites·6 claims
- 2059US5968514AMethods for stimulating immune responses in a host through the administration of superantigen peptides derived from human immunodeficiency virus type 1 NefUNIV FLORIDA·Filed 1994·Granted Oct 19, 1999·18 cites·6 claims
- 2158US2002013452A1Interferon tau compositions and methods of useUNIV FLORIDA·Filed 2000·Application pending·0 cites
- 2247US2016289288A1Type i interferon mimetics as therapeutics for cancer, viral infections, and other diseasesUNIV FLORIDA·Filed 2014·Application pending·0 cites
- 2347US2006257364A1Materials and methods for inhibition of IgE productionJOHNSON HOWARD M·Filed 2006·Application pending·0 cites
- 2446US2004131589A1Materials and methods for inhibition of IgE productionFiled 2003·Application pending·0 cites
- 2537US9951111B2Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosisUNIV FLORIDA·Filed 2013·Granted Apr 24, 2018·0 cites·20 claims
- 2636US11603387B2SOCS mimetics for the treatment of diseasesUNIV FLORIDA·Filed 2015·Granted Mar 14, 2023·0 cites·35 claims
- 2727US4786631ANovel arginine vasopressin-binding peptidesUNIV FLORIDA·Filed 1988·Granted Nov 22, 1988·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Howard M. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →